Y.A. Hassan et al.
Carbohydrate Polymers 260 (2021) 117834
antimicrobial efficacy of Zn(II) as an antibacterial (Abendrot et al.,
2.1. Essential oil extraction and analysis
2
020; Atmaca, Gül, & Çiçek, 1998; Joseyphus & Nair, 2008), as well as
an antifungal (Jaafar et al., 2020; Joseyphus & Nair, 2008), were known
for a long time.
2.1.1. Plant material and extraction of O. syriacum essential oil (OSEO)
Samples of Origanum syriacum L. (O. syriacum) plants have been
collected from cultivated plants grown in El Arish, Egypt. The collected
plant materials were air-dried in shade for one week and then manually
cut into small pieces followed by ground into a moderately coarse
powder.
Metallosalens are quite versatile coordination compounds having
many applications such as catalysis, chemical sensing, medicinal, and
pharmacological (Erxleben, 2018; Pessoa & Correia, 2019). Further-
more, previous studies revealed the diverse pharmacological effects for
metallosalens such as; antimicrobial (Musa, Khan, Aspedon, & Cooper-
wood, 2010; Nworie, 2016; Pessoa & Correia, 2019), anticancer
The Egyptian Pharmacopoeia protocol was followed to extract OSEO
from the fresh and pre-dried oregano plant. In brief, 100 g of fresh or
pre-dried powdered Egyptian O. syriacum plant materials were hydro-
(
Abdalla et al., 2020; Erxleben, 2018; Pessoa & Correia, 2019), and
◦
antiviral (Tarasconi, Capacchi, & Pelosi, 2000). Several Zn(II)Salen
distilled at 100 C for 3 h using conventional Clevenger-type hydro-
complexes were reported to have remarkable antimicrobial efficacies
distillation apparatus. The extracted oil was collected, dissolved in
◦
(
Inba, Annaraj, Thalamuthu, & Neelakantan, 2013; Khan, Nami, Bhat,
Kareem, & Nishat, 2017; Mukhopadhyay, Kundu, Porwal, & Mobin,
020). In addition, the biocompatible nature of Zn(II) ions and its salen
hexane, dried over anhydrous Na
use.
2 4
SO , and stored at 4ꢀ 6 C for further
2
complexes coupled with their minimal cytotoxicity make them prom-
ising templates for the development of new pharmacological agents
2.1.2. Analysis of OSEO by gas chromatography-mass spectrometry
analysis (GC–MS)
(
Kumar, Roopa, Bhalla, & Kumar, 2021).
The chemical composition of extracted essential oil was investigated
by GC–MS technique using an HP-5890 II gas chromatograph equipped
with an HP-5972 mass-selective detector in electron impact mode (70
Interestingly, recently it was reported the potential for EOs to act
synergistically with antimicrobials and antioxidants compounds for
significantly enhanced bioactivity (Hadidi, Pouramin, Adinepour
Haghani, & Jafari, 2020; Halevas et al., 2017). Therefore, combinations
of synthetic and natural antimicrobials, such as EOs, may offer one of the
most promising approaches to overcome microbial resistance to anti-
biotics. Nano-encapsulation of bioactive compounds using
biopolymers-based nanomaterials also provide an additional promising
weapon in fighting multidrug resistant infections (Detsi et al., 2020;
Gupta, Mumtaz, Li, Hussain, & Rotello, 2019; Yahya et al., 2020).
Nano-encapsulation can also address drawbacks related to drug solubi-
lity (Detsi et al., 2020).
eV). Analytical conditions: injector and MS transfer line temperatures,
◦
220 and 240 C, respectively; injection, 2
μ
L (10 % hexane solution);
◦
◦
ꢀ 1
oven temperature, 60ꢀ 240 C with heating rate 3 C min ; carrier gas,
ꢀ
1
He at 1 mL min . The constituents of OSEO were identified by com-
parison of their respective relative retention times and mass spectra with
those of authentic samples, on the basis of their relative retention indices
(RRI) to a series of n-alkanes. Further identifications were performed
with aid of the NBS75 K library of mass spectra created from pure
components of known oils, and their respective MS literature data
(Adams, 2001).
The incredible features of chitosan (CS) and thus chitosan nano-
particles (CSNPs) (Divya & Jisha, 2018) make it the best choice in drug
delivery systems (Elbehairi, Ismail, Alfaifi, Elshaarawy, & Hafez, 2020).
To this end, CSNPs are acting as a promising class of bioactive encap-
sulators for many drugs delivers (Divya & Jisha, 2018).
2.2. Synthesis of Salen ligand and its Zn(II) complex
2.2.1. Synthesis of Salen ligand (4)
This ligand was prepared in accordance with our earlier work
(Alfaifi, Elbehairi, Hafez, & Elshaarawy, 2019) with slight modification,
in brief, a solution of isopropylsalicylaldehyde-butylimidazolium chlo-
Inspired by the aforesaid outstanding facts and in the continuity of
our relentless efforts in designing new smart chitosan-based bioactive
materials (Elshaarawy, Refaee, & El-Sawi, 2016, Elshaarawy et al.,
i
n
+
ride (H( Pr)sal( BuIm Cl–), 3) (673.7 mg, 2.0 mmol) in dry ethanol (25
mL) was mixed with an ethanolic solution (10 mL) of ethylenediamine
(60.1 mg, 1.0 mmol) in a Schlenk system under vigorous stirring at room
temperature for 5 h. After completion of the reaction as judged by
thin-layer chromatography (TLC), the solvent was removed in vacuo and
the residue was subjected to a silica gel column chromatography using a
mixture of n-hexane-ethyl acetate (9:1) as an eluent to give a pure salen
ligand (1297.8 mg, 93 % yield) as a pale orange solid which dried and
2
017; Sofy, Hmed, Abd El Haliem, Zein, & Elshaarawy, 2019), the
present study aimed to investigate the synergistic behavior of EO with
new bioactive Zn(II)Salen complex through co-encapsulation by CSNPs,
targeting multifunctional pharmaceutical nanocomposites. Despite
several studies have reported the antimicrobial action of essential oils
enveloped with chitosan matrices (Detsi et al., 2020; Yahya et al., 2020),
nevertheless, no work has been reported for the fabrication of nano-
pharmaceuticals incorporating several pharmacophores (OSEO, metal-
losalen, and imidazolium ionic liquid terminals) which may induce
several biocidal mechanisms inside the microbial cells to overcome the
self-microbial resistance.
◦
preserved in a desiccator for further use, mp 89–91 C. FT-IR (KBr,
ꢀ 1
cm ): 3432 (m, br), 3131 (m, sh), 3069 (m, sh), 2960 (s, sh), 2933 (s,
sh), 2864 (s, sh), 1630 (vs, sh), 1560 (s, sh), 1464 (s, sh), 1382 (m, sh),
1272 (s, sh), 1156 (s, sh), 1099 (s, sh), 953 (w, sh), 862 (m, sh), 773 (m,
sh), 645 (m, sh), 502 (w, br). 1H NMR (200 MHz, DMSO-d
14.02 (s, 2 H), 9.47 (s, 2 H), 8.54 (s, 2 H), 7.83 (d, J =1.97 Hz, 2 H), 7.37
) δ (ppm):
6
2
. Materials and methods
(
d, J =1.58 Hz, 2 H), 7.17 (s, 2 H), 6.98 (s, 2 H), 5.37 (s, 4 H), 4.18 (t, J
Specifications of materials used in this work coupled with their
=7.0 Hz, 4 H), 3.96 (t, J =7.1 Hz, 4 H), 3.44ꢀ 3.33 (m, 2 H), 2.15ꢀ 1.92
(m, 4 H), 1.89ꢀ 1.60 (m, 4 H) 1.16 (d, J =5.2 Hz, 12 H), 0.89 (t, J =7.4
suppliers, different techniques utilized for the comprehensive charac-
terization of the prepared samples (such as Fourier-transform infrared
Hz, 6 H). 13C NMR (125 MHz, DMSO-d ) δ (ppm): 159.21, 157.92,
6
(
(
FTIR), Ultraviolet–Visible (UV–vis), Nuclear magnetic resonance
NMR) spectroscopy, Electrospray ionization mass spectrometry (ESI-
139.64, 138.61, 132.12, 129.75, 127.34, 125.16, 123.96, 122.71, 63.11,
57.05, 48.57, 34.85, 28.33, 23.87, 21.47, 14.42. ESI MS: m/z 662.2
+
+
MS), Thermogravimetric analysis (TGA), and Scanning electron micro-
scopy (SEM)) are shown in the electronic supplementary information
(<5%, [C38
H
ClN O ]
=
[M
+
–
Cl–] ) and 331.1 (20 %,
54
6 2
2
+
[C38H54CN O ] = [M – 2 Cl–] ). Anal. Calcd. for C38H54Cl N O (M =
6
2
2 6 2
(
ESIy). Moreover, the practical protocol used in the preparation of the
new ionic liquid, isopropylsalicylaldehyde-butylmidazolium chloride
3), was also described in the ESIy.
697.79): C, 65.41; H, 7.80; N, 12.04; Found: C, 65.28; H, 7.83; N, 12.07.
(
2.2.2. Synthesis of Zn(II)Salen complex
A solution of the salen-bis(imidazolium) salts H
Cl–) (4) was prepared by dissolving a certain amount of salen ligand
0.7 g, 1 mmol) in ethanol (10 mL). Then a solution of ZnCl (0.14 g, 1
(iPr)
salen(BuIm -
+
2 2
2
(
2
2